- Home
- GILD vs SO Comparison
GILD vs SO Comparison
Compare GILD & SO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- SO
- Stock Information
- Founded
- GILD 1987
- SO 1945
- Country
- GILD United States
- SO United States
- Employees
- GILD N/A
- SO N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- SO Power Generation
- Sector
- GILD Health Care
- SO Utilities
- Exchange
- GILD Nasdaq
- SO Nasdaq
- Market Cap
- GILD 113.0B
- SO 97.0B
- IPO Year
- GILD 1992
- SO N/A
- Fundamental
- Price
- GILD $93.94
- SO $82.89
- Analyst Decision
- GILD Buy
- SO Buy
- Analyst Count
- GILD 26
- SO 15
- Target Price
- GILD $96.71
- SO $88.71
- AVG Volume (30 Days)
- GILD 7.2M
- SO 3.9M
- Earning Date
- GILD 02-11-2025
- SO 02-13-2025
- Dividend Yield
- GILD 3.28%
- SO 3.47%
- EPS Growth
- GILD N/A
- SO 55.58
- EPS
- GILD 0.10
- SO 4.29
- Revenue
- GILD $28,299,000,000.00
- SO $26,428,000,000.00
- Revenue This Year
- GILD $6.50
- SO $7.82
- Revenue Next Year
- GILD $0.36
- SO $3.70
- P/E Ratio
- GILD $929.26
- SO $19.38
- Revenue Growth
- GILD 3.31
- SO 0.66
- 52 Week Low
- GILD $62.07
- SO $65.80
- 52 Week High
- GILD $98.90
- SO $94.45
- Technical
- Relative Strength Index (RSI)
- GILD 57.65
- SO 39.22
- Support Level
- GILD $90.27
- SO $81.38
- Resistance Level
- GILD $94.05
- SO $83.17
- Average True Range (ATR)
- GILD 1.99
- SO 1.30
- MACD
- GILD 0.07
- SO 0.06
- Stochastic Oscillator
- GILD 82.30
- SO 30.96
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About SO Southern Company (The)
Southern is one of the largest utilities in the U.S. The company serves 9 million customers with vertically integrated electric utilities in three states and natural gas distribution utilities in four states. It owns 50 gigawatts of rate-regulated generating capacity, primarily for serving customers in Georgia, Alabama, and Mississippi. Subsidiary Southern Power owns 13 gigawatts of natural gas generation and renewable energy across the U.S. and sells the electricity primarily under long-term contracts.